Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kimberly Jordan

Concepts (324)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
9
2026
595
1.500
Why?
Tumor Microenvironment
12
2026
735
1.350
Why?
T-Lymphocytes
11
2022
1997
1.110
Why?
Cancer Vaccines
7
2021
162
1.100
Why?
Myeloid-Derived Suppressor Cells
6
2026
76
1.100
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2025
1969
0.820
Why?
Antigens, Neoplasm
6
2021
271
0.730
Why?
Receptors, Antigen, T-Cell
7
2021
673
0.670
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.650
Why?
Baculoviridae
3
2009
44
0.620
Why?
Cytoreduction Surgical Procedures
1
2020
69
0.620
Why?
Chemotherapy, Adjuvant
1
2020
427
0.580
Why?
Image Processing, Computer-Assisted
1
2023
782
0.570
Why?
Insecta
3
2009
71
0.550
Why?
Neoadjuvant Therapy
2
2022
467
0.550
Why?
Extracellular Vesicles
1
2020
171
0.540
Why?
Melanoma
4
2023
761
0.500
Why?
Colorectal Neoplasms
4
2025
868
0.500
Why?
Granulocytes
1
2017
82
0.500
Why?
Pancreatic Cyst
1
2017
50
0.480
Why?
Lymphocyte Activation
4
2017
1133
0.470
Why?
Monocytes
2
2020
539
0.440
Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2025
133
0.430
Why?
CD8-Positive T-Lymphocytes
7
2024
923
0.430
Why?
Vaccines
2
2010
389
0.430
Why?
Spleen
1
2017
508
0.430
Why?
Cystadenocarcinoma, Serous
2
2026
89
0.420
Why?
Xenograft Model Antitumor Assays
8
2025
936
0.410
Why?
Programmed Cell Death 1 Receptor
3
2022
266
0.410
Why?
Myeloid Cells
2
2020
147
0.400
Why?
Neoplasms
6
2017
2913
0.390
Why?
Vaccines, Subunit
2
2012
53
0.390
Why?
Cell Line, Tumor
11
2026
3551
0.380
Why?
Tomography, X-Ray Computed
1
2023
2770
0.380
Why?
Histone-Lysine N-Methyltransferase
2
2024
141
0.370
Why?
Mice, Inbred BALB C
10
2026
1261
0.360
Why?
Complementarity Determining Regions
1
2012
54
0.360
Why?
Mice
26
2026
18357
0.340
Why?
Gamma Rays
2
2021
57
0.320
Why?
Benzimidazoles
2
2024
189
0.320
Why?
Antibodies, Monoclonal, Humanized
4
2025
992
0.300
Why?
Antineoplastic Agents, Immunological
4
2020
198
0.300
Why?
Inflammation
1
2020
2883
0.290
Why?
CD47 Antigen
2
2025
42
0.270
Why?
H-2 Antigens
1
2008
111
0.260
Why?
Breast Neoplasms
1
2020
2393
0.260
Why?
Female
32
2026
79025
0.260
Why?
Immunotherapy
5
2021
667
0.260
Why?
Pancreatic Neoplasms
3
2021
928
0.260
Why?
Animals
29
2026
38100
0.260
Why?
Cell Proliferation
7
2024
2514
0.250
Why?
Antigens
1
2009
348
0.250
Why?
Carcinoma, Pancreatic Ductal
2
2021
293
0.250
Why?
Drug Resistance, Neoplasm
4
2025
883
0.250
Why?
Proteome
2
2022
514
0.250
Why?
Peptide Library
4
2013
91
0.240
Why?
Tumor Escape
2
2017
49
0.240
Why?
Receptors, Interleukin-8B
1
2026
29
0.240
Why?
Peptides
4
2021
998
0.240
Why?
Survival Analysis
4
2021
1378
0.240
Why?
Vaccination
3
2010
1428
0.240
Why?
Disease Models, Animal
6
2026
4569
0.230
Why?
Granuloma
1
2026
97
0.230
Why?
Humans
46
2026
145750
0.230
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
153
0.230
Why?
Phthalazines
1
2025
63
0.220
Why?
Transcriptome
2
2022
1043
0.220
Why?
Lupus Nephritis
1
2025
67
0.220
Why?
Lung Neoplasms
3
2024
2667
0.220
Why?
Class I Phosphatidylinositol 3-Kinases
1
2025
108
0.220
Why?
Models, Biological
2
2021
1764
0.220
Why?
Major Histocompatibility Complex
4
2021
233
0.210
Why?
Tryptophan Oxygenase
1
2024
33
0.200
Why?
Keratins
1
2024
171
0.200
Why?
Bevacizumab
1
2024
168
0.200
Why?
Interferons
2
2022
186
0.200
Why?
beta Catenin
1
2025
254
0.200
Why?
Signal-To-Noise Ratio
1
2023
73
0.200
Why?
Neoplasms, Experimental
2
2021
167
0.190
Why?
Piperazines
1
2025
375
0.190
Why?
Tuberculosis
1
2026
284
0.190
Why?
Disease Progression
5
2026
2865
0.190
Why?
Mycobacterium tuberculosis
1
2026
318
0.190
Why?
Fallopian Tubes
1
2022
33
0.190
Why?
Artifacts
1
2023
143
0.190
Why?
Prognosis
5
2024
4329
0.190
Why?
Dendritic Cells
4
2020
500
0.190
Why?
Macrophages
3
2026
1507
0.190
Why?
Ephrin-B2
2
2021
45
0.180
Why?
Small Cell Lung Carcinoma
1
2024
122
0.180
Why?
Carcinoma, Non-Small-Cell Lung
2
2022
1191
0.180
Why?
Fibrosis
2
2024
561
0.180
Why?
Neoplasms, Second Primary
1
2023
102
0.180
Why?
Tretinoin
2
2023
125
0.170
Why?
Flow Cytometry
5
2022
1165
0.170
Why?
Blood
1
2022
107
0.170
Why?
Mycosis Fungoides
1
2021
63
0.170
Why?
Gene Expression Profiling
3
2021
1777
0.170
Why?
ADAM10 Protein
1
2021
29
0.170
Why?
Middle Aged
12
2025
36297
0.160
Why?
Ovary
1
2022
234
0.160
Why?
Synovial Membrane
1
2022
123
0.160
Why?
Precision Medicine
1
2025
461
0.160
Why?
Seroconversion
1
2021
48
0.160
Why?
Amyloid Precursor Protein Secretases
1
2021
78
0.160
Why?
Proteomics
3
2024
1188
0.160
Why?
Oligonucleotides, Antisense
1
2020
120
0.160
Why?
Databases, Genetic
1
2021
238
0.160
Why?
Eosinophilic Esophagitis
1
2024
332
0.160
Why?
Immunity
1
2020
140
0.150
Why?
Splenectomy
1
2020
61
0.150
Why?
Radiation Injuries
1
2021
149
0.150
Why?
Diagnostic Imaging
1
2022
337
0.150
Why?
Cell Adhesion
1
2020
451
0.150
Why?
Case-Control Studies
3
2022
3634
0.140
Why?
Receptor, EphB4
1
2019
33
0.140
Why?
Neoplasm Invasiveness
1
2020
508
0.140
Why?
Epithelial-Mesenchymal Transition
1
2021
220
0.140
Why?
STAT3 Transcription Factor
1
2020
206
0.140
Why?
Adrenal Cortex Neoplasms
1
2020
70
0.140
Why?
Survival Rate
2
2021
2094
0.140
Why?
Adrenocortical Carcinoma
1
2020
72
0.140
Why?
Radiosurgery
1
2022
399
0.140
Why?
Cell Communication
1
2020
328
0.140
Why?
T-Lymphocytes, Regulatory
3
2020
411
0.140
Why?
Interferon-alpha
1
2019
193
0.140
Why?
Isoxazoles
1
2018
56
0.140
Why?
Papillomavirus Infections
1
2022
344
0.140
Why?
Multiple Sclerosis
1
2024
489
0.140
Why?
Autoantigens
1
2021
427
0.140
Why?
Ipilimumab
1
2018
40
0.140
Why?
Mice, Transgenic
3
2024
2191
0.130
Why?
Immunophenotyping
3
2017
322
0.130
Why?
Biomarkers, Tumor
2
2022
1329
0.130
Why?
Antigens, CD19
1
2018
128
0.130
Why?
Metabolome
1
2021
391
0.130
Why?
Colonic Neoplasms
2
2012
258
0.130
Why?
Drug Discovery
1
2018
153
0.130
Why?
Head and Neck Neoplasms
1
2022
561
0.130
Why?
Lymphoma, Non-Hodgkin
1
2018
124
0.130
Why?
Combined Modality Therapy
1
2020
1270
0.130
Why?
Histone Deacetylase Inhibitors
1
2019
218
0.130
Why?
Adult
9
2025
40867
0.130
Why?
Oxidation-Reduction
1
2020
1068
0.120
Why?
Problem-Based Learning
1
2017
97
0.120
Why?
Spodoptera
2
2021
40
0.120
Why?
Students, Pharmacy
1
2017
96
0.120
Why?
Cell Count
1
2017
319
0.120
Why?
Adipose Tissue
1
2020
645
0.120
Why?
Triple Negative Breast Neoplasms
1
2019
218
0.120
Why?
Algorithms
1
2023
1850
0.110
Why?
Cytotoxicity, Immunologic
2
2020
224
0.110
Why?
Signal Transduction
4
2024
5223
0.110
Why?
Aged
7
2025
26212
0.110
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
297
0.110
Why?
Multiple Myeloma
1
2018
309
0.110
Why?
Neoplasm Recurrence, Local
1
2021
1150
0.110
Why?
Immunotherapy, Adoptive
1
2018
342
0.110
Why?
Perception
1
2017
378
0.110
Why?
Tumor Cells, Cultured
3
2021
887
0.110
Why?
Membrane Proteins
1
2021
1166
0.100
Why?
Skin Neoplasms
1
2021
852
0.100
Why?
Mice, Nude
3
2020
680
0.100
Why?
Liver Neoplasms
1
2020
777
0.100
Why?
Blood Cell Count
1
2013
55
0.100
Why?
Prostatic Neoplasms
1
2020
981
0.100
Why?
Lipopolysaccharide Receptors
1
2013
88
0.100
Why?
Arthritis, Rheumatoid
1
2022
1180
0.090
Why?
Immunohistochemistry
3
2022
1723
0.090
Why?
Interferon-gamma
2
2021
784
0.090
Why?
Male
12
2025
72992
0.090
Why?
Apoptosis
4
2024
2443
0.090
Why?
Down Syndrome
1
2019
525
0.090
Why?
Young Adult
3
2021
14250
0.090
Why?
Suppressor Factors, Immunologic
1
2011
4
0.090
Why?
Epitopes, T-Lymphocyte
1
2012
174
0.090
Why?
Cells, Cultured
2
2017
4151
0.090
Why?
Datasets as Topic
2
2022
118
0.080
Why?
B7-H1 Antigen
2
2024
244
0.080
Why?
Follow-Up Studies
1
2020
5428
0.080
Why?
Neoplasm Proteins
1
2013
442
0.080
Why?
Transcription Factors
1
2018
1736
0.080
Why?
Curriculum
1
2017
1074
0.080
Why?
Immunodominant Epitopes
1
2010
27
0.080
Why?
Biomarkers
4
2024
4302
0.080
Why?
Neoplasm Staging
1
2013
1474
0.070
Why?
Genes, MHC Class I
1
2009
37
0.070
Why?
Gene Expression Regulation, Neoplastic
2
2025
1450
0.070
Why?
Genetic Engineering
1
2009
88
0.070
Why?
Histocompatibility Antigens Class I
1
2010
202
0.070
Why?
Cell Survival
2
2024
1103
0.070
Why?
Complement System Proteins
2
2022
314
0.070
Why?
Histocompatibility Antigen H-2D
1
2008
20
0.070
Why?
Cross-Priming
1
2008
16
0.070
Why?
CD11c Antigen
1
2008
40
0.070
Why?
Adjuvants, Immunologic
1
2009
244
0.060
Why?
Neutrophils
2
2026
1125
0.060
Why?
Molecular Targeted Therapy
2
2020
440
0.060
Why?
RNA, Messenger
3
2024
2805
0.060
Why?
Bacterial Load
1
2026
67
0.060
Why?
Cell Culture Techniques
1
2009
375
0.060
Why?
Mice, Inbred C3H
1
2026
254
0.060
Why?
Phenylurea Compounds
1
2026
119
0.060
Why?
Nephrocalcinosis
1
2025
12
0.060
Why?
Gene Expression
2
2022
1478
0.060
Why?
Aged, 80 and over
2
2020
8346
0.060
Why?
Microsatellite Instability
1
2025
55
0.060
Why?
Immune Tolerance
1
2008
385
0.060
Why?
Cetuximab
1
2025
111
0.060
Why?
Adolescent
2
2025
22569
0.060
Why?
Drug Synergism
1
2025
354
0.050
Why?
Ligands
2
2022
668
0.050
Why?
Cisplatin
1
2026
345
0.050
Why?
Cancer-Associated Fibroblasts
1
2024
23
0.050
Why?
Cell Line
1
2010
2823
0.050
Why?
Histocompatibility Antigens
1
2024
102
0.050
Why?
Neuroendocrine Cells
1
2024
33
0.050
Why?
Microsatellite Repeats
1
2024
157
0.050
Why?
Neoplasm Grading
1
2024
311
0.050
Why?
Wnt Signaling Pathway
1
2025
212
0.050
Why?
Cell Differentiation
1
2011
2051
0.050
Why?
Kynurenine
1
2024
114
0.050
Why?
Recombinant Fusion Proteins
1
2025
666
0.050
Why?
Imidazoles
1
2024
247
0.050
Why?
Tryptophan
1
2024
182
0.050
Why?
Neuroendocrine Tumors
1
2024
119
0.050
Why?
Mice, Inbred C57BL
3
2021
5992
0.050
Why?
Desmin
1
2002
24
0.040
Why?
Myofibrils
1
2002
49
0.040
Why?
Sf9 Cells
1
2021
11
0.040
Why?
Lymphocytes
2
2020
376
0.040
Why?
Autophagy
1
2024
291
0.040
Why?
Tissue Distribution
1
2022
335
0.040
Why?
Hypoalbuminemia
1
2021
27
0.040
Why?
Cell- and Tissue-Based Therapy
1
2021
78
0.040
Why?
Access to Information
1
2021
48
0.040
Why?
Ranolazine
1
2020
23
0.040
Why?
Animals, Genetically Modified
1
2002
247
0.040
Why?
Carcinogenesis
1
2022
228
0.040
Why?
Cluster Analysis
1
2022
501
0.040
Why?
Seroepidemiologic Studies
1
2021
171
0.040
Why?
Enzyme Inhibitors
1
2024
821
0.040
Why?
Data Mining
1
2021
113
0.040
Why?
Receptors, CCR
1
2020
6
0.040
Why?
Cytokines
3
2018
2069
0.040
Why?
Platelet Count
1
2020
94
0.040
Why?
RNA, Viral
1
2024
692
0.040
Why?
Basophils
1
2020
52
0.040
Why?
Lymphocyte Subsets
1
2020
78
0.040
Why?
Hematopoiesis
1
2021
193
0.040
Why?
Interleukin-6
1
2024
779
0.040
Why?
Tumor Burden
1
2020
325
0.040
Why?
Leukocyte Count
1
2020
318
0.040
Why?
Mutation
1
2010
4090
0.040
Why?
Autoimmunity
1
2025
933
0.040
Why?
Swine
1
2002
826
0.040
Why?
Pancreaticoduodenectomy
1
2020
137
0.040
Why?
Postoperative Period
1
2020
351
0.040
Why?
Biological Availability
1
2018
145
0.030
Why?
Immunoglobulin G
1
2003
892
0.030
Why?
Automation
1
2018
104
0.030
Why?
Gene Knockdown Techniques
1
2019
334
0.030
Why?
Radiotherapy
1
2019
206
0.030
Why?
Killer Cells, Natural
1
2021
481
0.030
Why?
Complement Activation
1
2021
399
0.030
Why?
Structure-Activity Relationship
1
2018
563
0.030
Why?
Kidney
1
2025
1498
0.030
Why?
Inpatients
1
2022
553
0.030
Why?
Molecular Structure
1
2018
487
0.030
Why?
B-Lymphocytes
1
2003
872
0.030
Why?
Lipid Metabolism
1
2020
529
0.030
Why?
Aging
1
2008
1973
0.030
Why?
Protein Domains
1
2018
311
0.030
Why?
Homeostasis
1
2021
644
0.030
Why?
Drug Delivery Systems
1
2020
381
0.030
Why?
Cell Movement
1
2021
961
0.030
Why?
Administration, Oral
1
2018
867
0.030
Why?
Comorbidity
1
2021
1662
0.030
Why?
Education, Pharmacy
1
2017
120
0.030
Why?
Metabolomics
1
2021
733
0.030
Why?
Antibodies, Monoclonal
1
2022
1505
0.030
Why?
Educational Measurement
1
2017
326
0.030
Why?
Dose-Response Relationship, Drug
1
2018
2028
0.030
Why?
Severity of Illness Index
1
2022
2933
0.030
Why?
Program Evaluation
1
2017
943
0.020
Why?
Lung
1
2026
4116
0.020
Why?
Cross Reactions
1
2012
130
0.020
Why?
Antineoplastic Agents
1
2024
2219
0.020
Why?
Retrospective Studies
2
2021
17322
0.020
Why?
Muscle, Skeletal
1
2002
1791
0.020
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2011
56
0.020
Why?
Culture Media, Conditioned
1
2011
112
0.020
Why?
Endocytosis
1
2011
168
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
849
0.020
Why?
Hospitalization
1
2021
2460
0.020
Why?
Universities
1
2013
445
0.020
Why?
In Vitro Techniques
1
2011
1049
0.020
Why?
Treatment Outcome
1
2024
11793
0.020
Why?
Prospective Studies
1
2021
8075
0.020
Why?
Mice, Knockout
2
2008
3130
0.020
Why?
Enterotoxins
1
2006
89
0.010
Why?
T-Lymphocytes, Cytotoxic
1
2006
177
0.010
Why?
DNA Primers
1
2006
505
0.010
Why?
Drug Design
1
2006
175
0.010
Why?
Antigen Presentation
1
2006
208
0.010
Why?
Blood Cells
1
2003
38
0.010
Why?
CD40 Ligand
1
2003
40
0.010
Why?
Colorado
1
2013
4556
0.010
Why?
Coculture Techniques
1
2003
247
0.010
Why?
Toes
1
2002
16
0.010
Why?
Amino Acid Sequence
1
2006
2131
0.010
Why?
Sarcomeres
1
2002
97
0.010
Why?
Molecular Sequence Data
1
2006
2883
0.010
Why?
Antibody Formation
1
2003
288
0.010
Why?
Child
1
2021
22738
0.010
Why?
Microscopy, Electron
1
2002
414
0.010
Why?
Immunoglobulins
1
2002
163
0.010
Why?
Organ Size
1
2002
461
0.010
Why?
Cattle
1
2003
946
0.010
Why?
Echocardiography
1
2002
648
0.010
Why?
Birth Weight
1
2002
517
0.010
Why?
Biomechanical Phenomena
1
2002
860
0.010
Why?
Placenta
1
2002
787
0.010
Why?
Phenotype
1
2002
3170
0.010
Why?
Jordan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)